https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugunda-farmak-terapi-kanitlar-etkinlik-ve-tedavi-aciklari-tr/ 2026-09-01T14:39:30+00:00 https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugunda-naltreksone-dozlama-izleme-ve-karaciger-guvenligi-tr/ 2026-09-01T14:39:34+00:00 https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugunda-akamprosat-etki-mekanizmasi-dozlama-etkinlik-ve-guvenlilik-tr/ 2026-09-01T14:39:37+00:00 https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugunda-disulfiram-mekanizmalar-etkinlik-ve-hepatik-guvenlilik-degerlendirmeleri-tr/ 2026-09-01T14:39:42+00:00 https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugunda-gabapentin-topiramat-ve-baklofen-tr/ 2026-09-01T14:39:45+00:00 https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugu-algoritmasi-karaciger-durumuna-gore-ilac-secimi-tr/ 2026-09-01T14:39:49+00:00 https://tr.psychopharmacologyinstitute.com/section/solunum-ve-enfeksiyoz-komorbiditeleri-olan-alkol-kullanim-bozuklugu-ilac-duzenlemeleri-tr/ 2026-09-01T14:39:53+00:00 https://tr.psychopharmacologyinstitute.com/section/es-zamanli-kardiyovaskuler-ve-renal-hastaligi-olan-bireylerde-alkol-kullanim-bozuklugunun-yonetimi-tr/ 2026-09-01T14:39:57+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vaka-9209-tr/ 2026-09-01T14:40:01+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9210-tr/ 2026-09-01T14:40:04+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresan-kullanimi-ve-kesilme-kilavuzlarindaki-guncel-egilimler-tr/ 2026-09-01T14:40:12+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresan-yoksunlugunun-norobiyolojik-mekanizmalari-tr/ 2026-09-01T14:40:16+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresan-kesilme-sendromu-tanisi-nuksden-ayirt-edilmesi-tr/ 2026-09-01T14:40:20+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresan-ilac-azaltimi-klinik-gerekce-ve-yaygin-engeller-tr/ 2026-09-01T14:40:23+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlarin-hiperbolik-azaltilmasi-norobiyolojik-temel-tr/ 2026-09-01T14:40:27+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlarin-hiperbolik-azaltilmasi-klinik-kanitlar-tr/ 2026-09-01T14:40:31+00:00 https://tr.psychopharmacologyinstitute.com/section/hiperbolik-antidepresan-azaltiminin-uygulanmasi-formulasyon-secenekleri-ve-klinik-degerlendirmeler-tr/ 2026-09-01T14:40:35+00:00 https://tr.psychopharmacologyinstitute.com/section/ssri-ve-mirtazapin-depreskupsiyonu-hiperbolik-azaltma-teknikleri-tr/ 2026-09-01T14:40:39+00:00 https://tr.psychopharmacologyinstitute.com/section/snri-lerin-depreskupsiyonu-hiperbolik-azaltma-teknikleri-tr/ 2026-09-01T14:40:43+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vakalar-tr/ 2026-09-01T14:40:46+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9811-tr/ 2026-09-01T14:40:50+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotik-ilaclarin-yan-etkileri-reseptor-profillerine-genel-bakis-tr/ 2026-09-01T14:40:58+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklerin-neden-oldugu-sedasyonun-yonetimi-tr/ 2026-09-01T14:41:01+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklere-bagli-kilo-alimi-onleme-ve-yonetim-tr/ 2026-09-01T14:41:05+00:00 https://tr.psychopharmacologyinstitute.com/section/akatizi-ve-parkinsonizm-icin-tedavi-stratejileri-tr/ 2026-09-01T14:41:09+00:00 https://tr.psychopharmacologyinstitute.com/section/noroleptik-malign-sendrom-ve-akut-distoninin-taninmasi-ve-yonetimi-tr/ 2026-09-01T14:41:13+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklerin-yol-actigi-tardif-diskinezi-degerlendirme-ve-izlem-tr/ 2026-09-01T14:41:16+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotik-kaynakli-tardif-diskinezinin-tedavisi-tr/ 2026-09-01T14:41:20+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotik-kullanimina-bagli-hiperprolaktinemi-ve-cinsel-yan-etkilerin-yonetimi-tr/ 2026-09-01T14:41:24+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotik-tedavinin-kardiyak-yan-etkilerinin-yonetimi-tr/ 2026-09-01T14:41:28+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklere-bagli-ortostatik-hipotansiyon-ve-nobetlerin-yonetimi-tr/ 2026-09-01T14:41:31+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklere-bagli-gastrointestinal-sorunlar-siyalore-ve-konstipasyon-tr/ 2026-09-01T14:41:35+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9312-tr/ 2026-09-01T14:41:39+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-bozukluk-alt-tipleri-klasik-ve-atipik-prezentasyonlar-tr/ 2026-09-01T14:41:46+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonun-degerlendirilmesi-laboratuvar-testleri-duygudurum-cizelgeleri-ve-mizac-olcekleri-tr/ 2026-09-01T14:41:50+00:00 https://tr.psychopharmacologyinstitute.com/section/karisik-bipolar-depresyon-klinik-ozellikler-ve-tedavi-stratejileri-tr/ 2026-09-01T14:41:54+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyon-inflamatuvar-tip-tr/ 2026-09-01T14:41:58+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyon-vaskuler-tip-tr/ 2026-09-01T14:42:02+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonda-lityum-tr/ 2026-09-01T14:42:06+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonda-lamotrijin-tr/ 2026-09-01T14:42:10+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyon-icin-ikinci-kusak-antipsikotikler-tr/ 2026-09-01T14:42:15+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonda-adjuvan-tedaviler-pramipeksol-t3-ve-isik-terapisi-tr/ 2026-09-01T14:42:19+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyon-icin-modafinil-omega-3-ve-diger-ucuncu-basamak-secenekler-tr/ 2026-09-01T14:42:24+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonda-ketamin-tms-ve-ekt-tr/ 2026-09-01T14:42:28+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-cikarimlar-tr/ 2026-09-01T14:42:33+00:00 https://tr.psychopharmacologyinstitute.com/section/canmat-in-depresyon-icin-kanit-derecelendirmesi-ve-tedavi-basamaklarini-anlamak-tr/ 2026-09-01T14:42:41+00:00 https://tr.psychopharmacologyinstitute.com/section/depresyon-tedavisinde-isbirlikci-karar-verme-tr/ 2026-09-01T14:42:45+00:00 https://tr.psychopharmacologyinstitute.com/section/baslangic-depresyon-tedavisinin-secimi-tr/ 2026-09-01T14:42:49+00:00 https://tr.psychopharmacologyinstitute.com/section/depresyon-icin-tamamlayici-ve-alternatif-tip-canmat-onerileri-tr/ 2026-09-01T14:42:53+00:00 https://tr.psychopharmacologyinstitute.com/section/depresyonun-onlenmesine-yonelik-idame-tedavisi-tr/ 2026-09-01T14:42:56+00:00 https://tr.psychopharmacologyinstitute.com/section/tedavisi-guc-depresyonun-degerlendirilmesi-tr/ 2026-09-01T14:43:00+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-depresyonun-farmakolojik-yonetimi-birinci-ikinci-ve-ucuncu-basamak-secenekler-tr/ 2026-09-01T14:43:04+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-depresyonun-yonetiminde-norostimulasyon-stratejileri-tr/ 2026-09-01T14:43:08+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vaka-tedaviyi-optimize-etmek-icin-hastalarla-is-birligi-tr/ 2026-09-01T14:43:12+00:00 https://tr.psychopharmacologyinstitute.com/section/canmat-depresyon-kilavuzlari-temel-cikarimlar-tr/ 2026-09-01T14:43:15+00:00 https://tr.psychopharmacologyinstitute.com/section/perinatal-donemde-tedavi-engellerin-asilmasi-ve-guvenin-artirilmasi-tr/ 2026-09-01T14:43:23+00:00 https://tr.psychopharmacologyinstitute.com/section/gebeligin-ilac-etkinligi-uzerine-etkisi-ve-doz-ayarlama-degerlendirmeleri-tr/ 2026-09-01T14:43:27+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelikte-psikiyatrik-ilaclar-anne-ve-fetal-saglik-arasindaki-dengeyi-gozetmek-tr/ 2026-09-01T14:43:31+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelik-ve-emzirme-doneminde-lityum-tr/ 2026-09-01T14:43:35+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelikte-ssri-tedavisi-klinik-bir-vaka-tr/ 2026-09-01T14:43:39+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelikte-valproat-temel-degerlendirmeler-tr/ 2026-09-01T14:43:43+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelik-dehb-ve-stimulanlar-bilincli-bir-secim-yapmak-1-gebelikte-dehb-yonetimi-risk-ve-faydalarin-dengelenmesi-2-gebelikte-stimulan-guvenligi-bilincli-karar-verme-icin-kanitlar-3-gebe-kadinlarda-dehb/ 2026-09-01T14:43:47+00:00 https://tr.psychopharmacologyinstitute.com/section/perinatal-psikiyatri-kaynaklari-uzmanliginizi-gelistirin-tr/ 2026-09-01T14:43:51+00:00 https://tr.psychopharmacologyinstitute.com/section/ana-mesajlar-tr/ 2026-09-01T14:43:55+00:00 https://tr.psychopharmacologyinstitute.com/section/yasli-yetiskinlerde-psikotropik-ilac-kullanimindaki-egilimler-tr/ 2026-09-01T14:44:03+00:00 https://tr.psychopharmacologyinstitute.com/section/yasa-bagli-farmakolojik-degisiklikler-yasli-hastalarda-dikkat-edilmesi-gereken-hususlar-tr/ 2026-09-01T14:44:08+00:00 https://tr.psychopharmacologyinstitute.com/section/geriatrik-populasyonda-psikotropik-ilac-recetelemenin-guclukleri-tr/ 2026-09-01T14:44:12+00:00 https://tr.psychopharmacologyinstitute.com/section/yasli-eriskinlerde-ssri-ve-snri-kullaniminda-dikkat-edilmesi-gerekenler-dozlama-yan-etkiler-ve-izlem-tr/ 2026-09-01T14:44:16+00:00 https://tr.psychopharmacologyinstitute.com/section/geriatrik-populasyonda-mirtazapin-bupropion-tca-lar-ve-maoi-lerin-recetelenmesi-tr/ 2026-09-01T14:44:21+00:00 https://tr.psychopharmacologyinstitute.com/section/geriatrik-depresyonda-guclendirme-stratejileri-ve-ekt-tr/ 2026-09-01T14:44:25+00:00 https://tr.psychopharmacologyinstitute.com/section/yasli-eriskinlerde-duygudurum-duzenleyiciler-lityum-valproik-asit-ve-alternatif-ajanlar-tr/ 2026-09-01T14:44:29+00:00 https://tr.psychopharmacologyinstitute.com/section/yasli-eriskinlerde-antipsikotik-receteleme-klinik-degerlendirmeler-tr/ 2026-09-01T14:44:33+00:00 https://tr.psychopharmacologyinstitute.com/section/yasli-eriskinlerde-benzodiazepinler-ve-bra-lar-klinik-degerlendirmeler-tr/ 2026-09-01T14:44:37+00:00 https://tr.psychopharmacologyinstitute.com/section/demans-farmakoterapisi-kolinesteraz-inhibitorlerinden-anti-amiloid-tedavilere-tr/ 2026-09-01T14:44:41+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9611-tr/ 2026-09-01T14:44:45+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoniyi-anlamak-terminoloji-ve-alt-tipler-tr/ 2026-09-01T14:44:53+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoni-tanisi-degerlendirme-ipuclari-tr/ 2026-09-01T14:44:57+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoni-tanisi-lorazepam-testi-tr/ 2026-09-01T14:45:01+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoninin-ayirici-tanisi-ve-altta-yatan-nedenlerinin-belirlenmesi-tr/ 2026-09-01T14:45:05+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoni-de-tibbi-komplikasyonlar-ve-prognostik-degerlendirmeler-tr/ 2026-09-01T14:45:09+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoni-farmakoterapisi-benzodiyazepinlerin-rolu-tr/ 2026-09-01T14:45:13+00:00 https://tr.psychopharmacologyinstitute.com/section/noromodulasyon-tedavileri-katatoni-de-ekt-ve-rtms-tr/ 2026-09-01T14:45:17+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoni-yonetiminde-nmda-antagonistleri-amantadin-memantin-ve-ketamin-tr/ 2026-09-01T14:45:21+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoni-icin-diger-farmakolojik-stratejiler-zolpidem-bromokriptin-ve-kariprazin-tr/ 2026-09-01T14:45:25+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vaka-9410-tr/ 2026-09-01T14:45:28+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9411-tr/ 2026-09-01T14:45:32+00:00 https://tr.psychopharmacologyinstitute.com/section/insomniyi-tanimlamak-tani-ve-patofizyoloji-tr/ 2026-09-01T14:45:40+00:00 https://tr.psychopharmacologyinstitute.com/section/insomnia-epidemiyolojisi-ve-taramasi-tr/ 2026-09-01T14:45:44+00:00 https://tr.psychopharmacologyinstitute.com/section/uykusuzluk-icin-birinci-basamak-tedaviler-cbt-i-ya-odaklanma-tr/ 2026-09-01T14:45:48+00:00 https://tr.psychopharmacologyinstitute.com/section/dual-orexin-reseptor-antagonistleri-etkinlik-dozlama-ve-guvenlilik-tr/ 2026-09-01T14:45:52+00:00 https://tr.psychopharmacologyinstitute.com/section/insomni-icin-z-ilaclari-ve-benzodiazepinler-tr/ 2026-09-01T14:45:57+00:00 https://tr.psychopharmacologyinstitute.com/section/melatonerjik-agonistler-melatonin-ve-ramelteon-dozlama-kalite-ve-etkinlik-tr/ 2026-09-01T14:46:01+00:00 https://tr.psychopharmacologyinstitute.com/section/insomni-icin-antidepresanlar-doxepin-trazodone-ve-mirtazapin-tr/ 2026-09-01T14:46:04+00:00 https://tr.psychopharmacologyinstitute.com/section/insomni-icin-antipsikotikler-antihistaminikler-ve-magnezyum-tr/ 2026-09-01T14:46:08+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelikte-ve-yasli-yetiskinlerde-insomni-daha-guvenli-ajanin-secimi-tr/ 2026-09-01T14:46:13+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vaka-perimenopozal-insomnia-icin-eszopiklon-tr/ 2026-09-01T14:46:16+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-cikarimlar-10811-tr/ 2026-09-01T14:46:20+00:00 https://tr.psychopharmacologyinstitute.com/section/giris-ve-hastalari-lityum-kullanmaya-ikna-etme-tr/ 2026-09-01T14:46:28+00:00 https://tr.psychopharmacologyinstitute.com/section/lityumun-baslangic-tetkikleri-izlemi-ve-optimal-dozlanmasi-tr/ 2026-09-01T14:46:32+00:00 https://tr.psychopharmacologyinstitute.com/section/lityum-tedavisinin-renal-yan-etkilerinin-yonetimi-tr/ 2026-09-01T14:46:36+00:00 https://tr.psychopharmacologyinstitute.com/section/lityumun-yol-actigi-kilo-alimi-ve-gastrointestinal-yan-etkilerle-nasil-basa-cikilir-tr/ 2026-09-01T14:46:39+00:00 https://tr.psychopharmacologyinstitute.com/section/lityumla-iliskili-tiroid-ve-paratiroid-disfonksiyonunun-yonetimi-tr/ 2026-09-01T14:46:44+00:00 https://tr.psychopharmacologyinstitute.com/section/lityum-ile-bilissel-bozulma-ve-tremoru-yonetmek-tr/ 2026-09-01T14:46:48+00:00 https://tr.psychopharmacologyinstitute.com/section/lityumla-iliskili-cinsel-disfonksiyon-sac-dokulmesi-ve-dokuntulere-yaklasim-tr/ 2026-09-01T14:46:52+00:00 https://tr.psychopharmacologyinstitute.com/section/vaka-kompleks-bipolar-bozuklugu-olan-bir-hastanin-yonetiminde-lityum-tr/ 2026-09-01T14:46:56+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-8709-tr/ 2026-09-01T14:47:00+00:00 https://tr.psychopharmacologyinstitute.com/section/menopozu-anlamak-klinik-tanimlar-ve-semptom-genel-bakisi-tr/ 2026-09-01T14:47:08+00:00 https://tr.psychopharmacologyinstitute.com/section/perimenopozal-depresyon-klinik-prezentasyon-ve-norobiyolojik-mekanizmalar-tr/ 2026-09-01T14:47:12+00:00 https://tr.psychopharmacologyinstitute.com/section/perimenopozal-depresyon-icin-risk-faktorlerinin-belirlenmesi-tr/ 2026-09-01T14:47:15+00:00 https://tr.psychopharmacologyinstitute.com/section/perimenopozal-depresyon-icin-antidepresanlar-tr/ 2026-09-01T14:47:19+00:00 https://tr.psychopharmacologyinstitute.com/section/perimenopozal-depresyon-icin-menopozal-hormon-tedavisi-mht-tr/ 2026-09-01T14:47:23+00:00 https://tr.psychopharmacologyinstitute.com/section/menopozun-vazomotor-semptomlarinin-vms-yonetimi-ssri-lar-snri-lar-ve-bdt-icin-kanitlar-tr/ 2026-09-01T14:47:28+00:00 https://tr.psychopharmacologyinstitute.com/section/perimenopozal-anksiyete-sicak-basmasi-ile-panik-atagin-ayirt-edilmesi-ve-allopregnanolonun-rolu-tr/ 2026-09-01T14:47:31+00:00 https://tr.psychopharmacologyinstitute.com/section/perimenopozal-anksiyete-farmakolojik-yonetim-tr/ 2026-09-01T14:47:36+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9509-tr/ 2026-09-01T14:47:39+00:00 https://tr.psychopharmacologyinstitute.com/section/cinsel-islev-biyopsikososyal-ve-norobiyolojik-perspektifler-tr/ 2026-09-01T14:47:48+00:00 https://tr.psychopharmacologyinstitute.com/section/cinsel-islev-bozuklugu-belirti-yan-etki-ve-depresyon-icin-risk-faktoru-olarak-tr/ 2026-09-01T14:47:53+00:00 https://tr.psychopharmacologyinstitute.com/section/cinsel-islev-bozuklugunu-etkileyen-tibbi-durumlar-ve-psikiyatri-disi-ilaclar-tr/ 2026-09-01T14:47:57+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresan-kaynakli-cinsel-islev-bozuklugu-mekanizmalar-genetik-ve-prevalans-tr/ 2026-09-01T14:48:02+00:00 https://tr.psychopharmacologyinstitute.com/section/dusuk-cinsel-islev-bozuklugu-riski-tasiyan-antidepresanlar-klinik-calisma-kanitlari-tr/ 2026-09-01T14:48:06+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklerin-duygudurum-dengeleyicilerin-ve-benzodiyazepinlerin-cinsel-yan-etkileri-tr/ 2026-09-01T14:48:10+00:00 https://tr.psychopharmacologyinstitute.com/section/cinsel-islev-hakkinda-iletisim-kurmak-klinik-bir-zorunluluk-tr/ 2026-09-01T14:48:15+00:00 https://tr.psychopharmacologyinstitute.com/section/sri-ye-bagli-cinsel-islev-bozuklugunun-yonetimi-ilac-degisikligi-antidotlar-ve-degistirilebilir-faktorler-tr/ 2026-09-01T14:48:19+00:00 https://tr.psychopharmacologyinstitute.com/section/vaka-cinsel-islev-bozuklugunun-gozden-kacan-bir-nedeni-olarak-oral-kontraseptifler-tr/ 2026-09-01T14:48:24+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9910-tr/ 2026-09-01T14:48:28+00:00 https://tr.psychopharmacologyinstitute.com/section/ilaca-bagli-hareket-bozukluklarina-giris-tr/ 2026-09-01T14:48:36+00:00 https://tr.psychopharmacologyinstitute.com/section/akatizi-nasil-tani-konulur-ve-nasil-yonetilir-tr/ 2026-09-01T14:48:40+00:00 https://tr.psychopharmacologyinstitute.com/section/ekstrapiramidal-semptomlar-degerlendirme-ipuclari-tr/ 2026-09-01T14:48:44+00:00 https://tr.psychopharmacologyinstitute.com/section/psikotrop-ilaclara-bagli-tremor-tani-ve-tedavi-yonetimi-tr/ 2026-09-01T14:48:49+00:00 https://tr.psychopharmacologyinstitute.com/section/ekstrapiramidal-semptomlar-ilac-ve-hasta-risk-faktorleri-tr/ 2026-09-01T14:48:53+00:00 https://tr.psychopharmacologyinstitute.com/section/ekstrapiramidal-semptomlar-yonetim-stratejileri-tr/ 2026-09-01T14:48:57+00:00 https://tr.psychopharmacologyinstitute.com/section/tardif-diskinezi-klinik-ozellikler-epidemiyoloji-ve-mekanizmalar-tr/ 2026-09-01T14:49:01+00:00 https://tr.psychopharmacologyinstitute.com/section/tardif-diskinezi-tedavi-hiyerarsisi-tr/ 2026-09-01T14:49:04+00:00 https://tr.psychopharmacologyinstitute.com/section/psikotropik-ilaclarin-norobilissel-yan-etkilerini-anlamak-tr/ 2026-09-01T14:49:08+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9710-tr/ 2026-09-01T14:49:12+00:00 https://tr.psychopharmacologyinstitute.com/section/benzodiazepin-azaltma-yeni-kilavuzlardan-temel-cikarimlar-tr/ 2026-09-01T14:49:20+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreni-tedavisinde-glp-1-ler-metabolik-yonetim-icin-semaglutid-recete-etmeli-miyiz-tr/ 2026-09-01T14:49:24+00:00 https://tr.psychopharmacologyinstitute.com/section/eikosapentaenoik-asit-tedaviye-direncli-depresyonda-etkili-bir-yardimci-tedavi-secenegi-mi-tr/ 2026-09-01T14:49:28+00:00 https://tr.psychopharmacologyinstitute.com/section/psikiyatride-ketojenik-diyetler-yeni-meta-analiz-sonuclari-tr/ 2026-09-01T14:49:32+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresan-azaltma-stratejilerinin-karsilastirilmasi-yeni-meta-analiz-bulgulari-tr/ 2026-09-01T14:49:36+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotik-kullanimi-madde-kullanimi-ve-sizofreni-hastalarinda-relaps-riski-arasindaki-iliskiler-2-ulusal-kohorttan-gercek-dunya-kanitlari-tr/ 2026-09-01T14:50:08+00:00 https://tr.psychopharmacologyinstitute.com/section/major-depresyon-icin-yeni-ve-gelismekte-olan-tedaviler-tr/ 2026-09-01T14:50:13+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-bozuklugu-olan-bireyler-icin-akilli-telefon-tabanli-oz-yonetim-mudahalesinin-relaps-semptom-yuku-ve-yasam-kalitesi-uzerine-etkileri-tr/ 2026-09-01T14:50:17+00:00 https://tr.psychopharmacologyinstitute.com/section/e-sigara-kullanim-oruntuleri-tatlar-ve-sigara-birakmaya-calisan-abd-li-yetiskinlerden-olusan-bir-orneklemde-sigarayi-birakmayla-iliskili-cihaz-ozellikleri-tr/ 2026-09-01T14:50:21+00:00 https://tr.psychopharmacologyinstitute.com/section/major-depresif-bozuklukta-ilac-gen-etkilesimleri-icin-farmakogenomik-testlemenin-ilac-secimi-ve-semptom-remisyonu-uzerindeki-etkisi-prime-care-randomize-klinik-calismasi-tr/ 2026-09-01T14:50:25+00:00 https://tr.psychopharmacologyinstitute.com/section/yogun-bakim-hastalarinda-deliriumun-tedavisinde-haloperidol-tr/ 2026-09-01T14:50:33+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelik-sirasinda-antidepresan-kullanimi-ve-gestasyonel-diyabet-riski-sistematik-derleme-ve-meta-analiz-tr/ 2026-09-01T14:50:37+00:00 https://tr.psychopharmacologyinstitute.com/section/dikkat-eksikligi-hiperaktivite-bozuklugu-tedavisinde-kullanilan-ilaclarla-iliskili-kardiyovaskuler-hastalik-riski-sistematik-derleme-ve-meta-analiz-tr/ 2026-09-01T14:50:41+00:00 https://tr.psychopharmacologyinstitute.com/section/esrar-baglantisallik-ve-yetiskinlige-gecis-ergenlikten-yetiskinlige-gecis-surecinde-esrar-kullanimi-ile-anterior-singulat-korteks-baglantisalligi-arasindaki-iliskiler-tr/ 2026-09-01T14:50:45+00:00 https://tr.psychopharmacologyinstitute.com/section/hormonal-kontraseptif-ve-antidepresan-kullaniminin-premenstruel-bozuklugu-olan-kadinlarda-intihar-davranisi-ve-kaza-riskleri-uzerine-etkisi-ulusal-capli-bir-kohort-calismasi-tr/ 2026-09-01T14:50:48+00:00 https://tr.psychopharmacologyinstitute.com/section/parkinson-hastaligi-psikozunda-pimavanserin-ve-diger-atipik-antipsikotiklerin-karsilastirmali-etkinligi-guvenilirligi-ve-kabul-edilebilirligi-sistematik-derleme-ve-ag-meta-analizi-tr/ 2026-09-01T14:50:57+00:00 https://tr.psychopharmacologyinstitute.com/section/insomni-tedavisinde-dual-orexin-reseptor-antagonistleri-suvorexant-ve-lemborexant-in-randomize-cift-kor-plasebo-kontrollu-calismalarina-iliskin-sistematik-derleme-ve-meta-analiz-tr/ 2026-09-01T14:51:00+00:00 https://tr.psychopharmacologyinstitute.com/section/kokain-arzusunun-farmakolojik-tedavileri-ileriye-giden-yol-nedir-sistematik-bir-derleme-tr/ 2026-09-01T14:51:05+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreni-ve-klozapin-rejimine-yanitsizlik-veya-intolerans-durumunda-ucuncu-nesil-antipsikotikler-kanitlar-ne-gosteriyor-tr/ 2026-09-01T14:51:09+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreni-sizofreniform-bozukluk-veya-bipolar-i-bozuklugu-olan-ve-hastaliginin-erken-doneminde-bulunan-genc-yetiskinlerde-olanzapin-samidorfan-randomize-kontrollu-enlighten-early-calismasinin-sonuclar/ 2026-09-01T14:51:13+00:00 https://tr.psychopharmacologyinstitute.com/section/cade-hastaligi-ve-otesi-yanlis-tani-antidepresan-kullanimi-ve-bipolar-spektrum-bozuklugu-icin-onerilen-bir-tanim-tr/ 2026-09-01T14:51:21+00:00 https://tr.psychopharmacologyinstitute.com/section/karisik-prezentasyonlu-bipolar-bozukluk-hastalarinin-yonetimine-iliskin-kanada-duygudurum-ve-anksiyete-tedavileri-agi-canmat-ve-uluslararasi-bipolar-bozukluklar-dernegi-isbd-onerileri-tr/ 2026-09-01T14:51:25+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlarin-depresyondaki-etkinligine-iliskin-kanit-tabanindaki-metodolojik-sinirliliklarin-degerlendirilmesi-bir-ag-meta-analizinin-yeniden-analizi-tr/ 2026-09-01T14:51:29+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresan-yoksunlugunu-nuksten-ayirt-etmek-klinik-uygulama-ve-antidepresan-kesim-calismalari-tr/ 2026-09-01T14:51:33+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-bozukluklu-hastalarin-yonetimine-iliskin-kanada-duygudurum-ve-anksiyete-tedavileri-agi-canmat-ve-uluslararasi-bipolar-bozukluklar-dernegi-isbd-2018-kilavuzlari-tr/ 2026-09-01T14:51:37+00:00 https://tr.psychopharmacologyinstitute.com/section/breksanolon-un-postpartum-depresif-semptomlar-anksiyete-ve-insomni-uzerine-etkisi-tr/ 2026-09-01T14:51:44+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreni-ve-tip-2-diyabetli-hastalarda-aripiprazol-recetesiyle-birlikte-kullaniminin-prolaktin-duzeylerine-etkisi-tr/ 2026-09-01T14:51:48+00:00 https://tr.psychopharmacologyinstitute.com/section/tardive-sendromlar-klinik-bulgular-ve-tedavi-stratejileri-tr/ 2026-09-01T14:51:52+00:00 https://tr.psychopharmacologyinstitute.com/section/farmakogenomik-testinin-major-depresif-bozuklukta-klinik-sonuclar-uzerindeki-etkisi-tr/ 2026-09-01T14:51:56+00:00 https://tr.psychopharmacologyinstitute.com/section/koloni-uyarici-faktorlerin-klozapin-yeniden-baslama-sonuclarina-etkisi-tr/ 2026-09-01T14:51:59+00:00 https://tr.psychopharmacologyinstitute.com/section/deliryum-riskini-azaltmada-nsaid-kullanimi-tr/ 2026-09-01T14:52:07+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofrenide-magduriyet-ve-siddetle-iliskisi-tr/ 2026-09-01T14:52:11+00:00 https://tr.psychopharmacologyinstitute.com/section/postpartum-depresyonunun-tedavisinde-zuranolone-tr/ 2026-09-01T14:52:15+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresan-ilaclarla-iliskili-apati-tr/ 2026-09-01T14:52:19+00:00 https://tr.psychopharmacologyinstitute.com/section/benzodiazepin-maruziyeti-sonrasinda-bebeklerde-malformasyon-riski-tr/ 2026-09-01T14:52:23+00:00 https://tr.psychopharmacologyinstitute.com/section/psikoz-tanili-yetiskinlerde-tutun-kullanimi-nikotin-bagimliligi-ve-sigarayi-birakma-tr/ 2026-09-01T14:52:32+00:00 https://tr.psychopharmacologyinstitute.com/section/obsesif-kompulsif-bozuklugun-farmakolojik-tedavisi-tr/ 2026-09-01T14:52:37+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlarla-iliskili-geri-donusumsuz-post-ssri-cinsel-islev-bozuklugu-riski-tr/ 2026-09-01T14:52:41+00:00 https://tr.psychopharmacologyinstitute.com/section/dual-orexin-reseptor-antagonistlerinin-deliryum-onleyici-etkileri-tr/ 2026-09-01T14:52:44+00:00 https://tr.psychopharmacologyinstitute.com/section/parkinson-hastaliginda-uyku-bozukluklari-tr/ 2026-09-01T14:52:48+00:00 https://tr.psychopharmacologyinstitute.com/section/maternal-depresyon-veya-antidepresan-maruziyeti-sonrasinda-neonatal-ve-gebelik-komplikasyonlari-tr/ 2026-09-01T14:52:56+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelik-surecinde-antidepresan-kesilmesi-ve-postpartum-psikiyatrik-sonuclar-tr/ 2026-09-01T14:52:59+00:00 https://tr.psychopharmacologyinstitute.com/section/major-depresif-bozuklugun-tedavisinde-lityum-augmentasyonu-tr/ 2026-09-01T14:53:03+00:00 https://tr.psychopharmacologyinstitute.com/section/karaciger-hastaliginda-antipsikotik-guvenligi-tr/ 2026-09-01T14:53:07+00:00 https://tr.psychopharmacologyinstitute.com/section/yasli-eriskinlerde-antidepresanlarla-birlikte-polifarmasi-ve-uygunsuz-ilac-kullanimi-tr/ 2026-09-01T14:53:11+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotik-ilaclar-ve-akut-pankreatit-riski-tr/ 2026-09-01T14:53:20+00:00 https://tr.psychopharmacologyinstitute.com/section/klozapin-ve-ultra-tedaviye-direncli-sizofrenide-elektrokonvulsif-terapi-ile-augmentasyonu-tr/ 2026-09-01T14:53:24+00:00 https://tr.psychopharmacologyinstitute.com/section/benzodiazepinlerle-iliskili-intihar-girisimi-ve-intihar-riski-tr/ 2026-09-01T14:53:28+00:00 https://tr.psychopharmacologyinstitute.com/section/silexan-in-post-covid-19-sendromundaki-potansiyel-faydalari-tr/ 2026-09-01T14:53:32+00:00 https://tr.psychopharmacologyinstitute.com/section/trazodon-insomni-icin-birinci-basamak-tedavi-olmali-mi-tr/ 2026-09-01T14:53:37+00:00 https://tr.psychopharmacologyinstitute.com/section/bariatrik-cerrahi-sonrasi-ssri-snri-konsantrasyonlari-ve-depresif-belirtiler-uzerine-etkileri-tr/ 2026-09-01T14:53:46+00:00 https://tr.psychopharmacologyinstitute.com/section/psikedelikler-donusturucu-terapotikler-tr/ 2026-09-01T14:53:50+00:00 https://tr.psychopharmacologyinstitute.com/section/komorbid-depresyon-ve-tibbi-hastaligi-olan-hastalarda-antidepresan-kullanimi-tr/ 2026-09-01T14:53:55+00:00 https://tr.psychopharmacologyinstitute.com/section/kronik-insomni-yonetiminde-daridorexant-kullanimi-tr/ 2026-09-01T14:53:59+00:00 https://tr.psychopharmacologyinstitute.com/section/klozapin-direncli-sizofreniye-yonelik-uluslararasi-bir-arastirma-gundemi-tr/ 2026-09-01T14:54:03+00:00 https://tr.psychopharmacologyinstitute.com/section/uykusuzluk-semptomlari-ve-saglik-ve-emeklilik-calismasinda-inme-riski-tr/ 2026-09-01T14:54:12+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofrenisi-olan-yetiskinlerde-antipsikotik-ilaclarin-uzun-donem-etkinligi-tr/ 2026-09-01T14:54:16+00:00 https://tr.psychopharmacologyinstitute.com/section/oral-antipsikotiklerin-cerrahi-sonrasi-eriskinlerde-advers-olaylar-acisindan-karsilastirmali-guvenlik-analizi-tr/ 2026-09-01T14:54:19+00:00 https://tr.psychopharmacologyinstitute.com/section/parkinson-hastaliginin-tedavisinde-medikal-kannabis-tr/ 2026-09-01T14:54:24+00:00 https://tr.psychopharmacologyinstitute.com/section/ilk-epizod-psikozda-nororadyolojik-anormalliklerin-prevalansi-tr/ 2026-09-01T14:54:28+00:00 https://tr.psychopharmacologyinstitute.com/section/major-depresif-bozuklugun-adjuvan-tedavisinde-kar-tr/ 2026-09-01T14:54:37+00:00 https://tr.psychopharmacologyinstitute.com/section/yasli-hastalarda-cerrahi-sonrasi-deliriumun-tedavisinde-dusuk-doz-risperidonun-etkinligi-tr/ 2026-09-01T14:54:41+00:00 https://tr.psychopharmacologyinstitute.com/section/trikotilomani-ve-deri-yolma-bozuklugunun-tedavisinde-memantin-in-etkinligi-tr/ 2026-09-01T14:54:45+00:00 https://tr.psychopharmacologyinstitute.com/section/psikiyatrik-bozukluklar-ve-ardindan-gelisen-kardiyovaskuler-hastalik-riski-tr/ 2026-09-01T14:54:49+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-bozukluk-farmakolojik-tedavilerinin-gercek-dunya-etkinligi-tr/ 2026-09-01T14:54:52+00:00 https://tr.psychopharmacologyinstitute.com/section/droperidol-un-ajitasyon-yonetimindeki-rolunu-yeniden-degerlendirmek-tr/ 2026-09-01T14:55:00+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlar-ve-psikoterapi-arasindaki-etkilesimi-anlamak-tr/ 2026-09-01T14:55:04+00:00 https://tr.psychopharmacologyinstitute.com/section/yatarak-tedavi-goren-yasli-hastalarda-benzodiazepinlerin-ve-z-ilaclarinin-kesilmesi-tr/ 2026-09-01T14:55:08+00:00 https://tr.psychopharmacologyinstitute.com/section/covid-19-hastalarinda-anozmia-etkileri-ve-potansiyel-tedaviler-tr/ 2026-09-01T14:55:12+00:00 https://tr.psychopharmacologyinstitute.com/section/yuksek-doz-olanzapin-tedaviye-direncli-sizofreni-icin-bir-secenek-midir-tr/ 2026-09-01T14:55:17+00:00 https://tr.psychopharmacologyinstitute.com/section/klozapin-ve-okb-benzeri-semptomlar-baglanti-nedir-tr/ 2026-09-01T14:55:24+00:00 https://tr.psychopharmacologyinstitute.com/section/valproat-ile-kilo-alimi-doza-bagimli-mi-tr/ 2026-09-01T14:55:28+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlarin-otesinde-tedaviye-direncli-depresyonda-dopamin-agonistleri-tr/ 2026-09-01T14:55:33+00:00 https://tr.psychopharmacologyinstitute.com/section/deliryum-demans-riskini-artirir-mi-tr/ 2026-09-01T14:55:37+00:00 https://tr.psychopharmacologyinstitute.com/section/uyarici-kullanim-bozuklugunun-tedavisine-yonelik-yeni-klinik-kilavuzlar-tr/ 2026-09-01T14:55:41+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofrenide-pnomoni-hangi-antipsikotikler-en-yuksek-riski-tasir-tr/ 2026-09-01T14:55:49+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklere-bagli-kilo-alimi-en-iyi-yonetim-stratejileri-tr/ 2026-09-01T14:55:53+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-bozuklukta-lityum-icin-optimal-terapotik-aralik-nedir-tr/ 2026-09-01T14:55:56+00:00 https://tr.psychopharmacologyinstitute.com/section/depresyon-b-vitaminleri-ve-kognisyon-bir-baglanti-var-mi-tr/ 2026-09-01T14:56:00+00:00 https://tr.psychopharmacologyinstitute.com/section/egzersizin-antidepresan-etkileri-onerilen-bir-cerceve-tr/ 2026-09-01T14:56:04+00:00 https://tr.psychopharmacologyinstitute.com/section/glp-1-agonistleri-alkol-kullanim-bozuklugunu-tedavi-edebilir-mi-tr/ 2026-09-01T14:56:11+00:00 https://tr.psychopharmacologyinstitute.com/section/hangi-antidepresanlar-en-fazla-kilo-aldirir-tr/ 2026-09-01T14:56:15+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlar-yasli-eriskinlerde-dusme-riskini-artiriyor-mu-tr/ 2026-09-01T14:56:19+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonda-ketamin-ve-esketamin-tr/ 2026-09-01T14:56:23+00:00 https://tr.psychopharmacologyinstitute.com/section/aripiprazol-gercekten-olanzapinden-metabolik-acidan-daha-guvenli-mi-tr/ 2026-09-01T14:56:28+00:00 https://tr.psychopharmacologyinstitute.com/section/uzun-etkili-enjektabler-sizofrenide-mortaliteyi-azaltmada-ustun-mu-tr/ 2026-09-01T14:56:36+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-bozuklugu-idame-tedavisi-optimal-doz-araligi-nedir-tr/ 2026-09-01T14:56:40+00:00 https://tr.psychopharmacologyinstitute.com/section/alzheimer-hastaligi-bpsd-icin-olanzapin-ve-risperidon-karsilastirmasi-tr/ 2026-09-01T14:56:44+00:00 https://tr.psychopharmacologyinstitute.com/section/lisdexamfetamin-metamfetamin-kullanim-bozuklugunu-tedavi-edebilir-mi-tr/ 2026-09-01T14:56:48+00:00 https://tr.psychopharmacologyinstitute.com/section/kronoterapi-sirkadiyen-ritimler-tedavi-etkinligini-etkileyebilir-mi-tr/ 2026-09-01T14:56:52+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonda-lurasidone-optimal-doz-nedir-tr/ 2026-09-01T14:57:01+00:00 https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugu-disulfiram-birinci-basamak-tedavi-olmali-mi-tr/ 2026-09-01T14:57:05+00:00 https://tr.psychopharmacologyinstitute.com/section/uyku-bozukluklarinda-melatonin-trazodon-veya-doksepin-tr/ 2026-09-01T14:57:09+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklere-iliskin-qt-uyarilari-gercek-kardiyak-riski-yansitiyor-mu-tr/ 2026-09-01T14:57:13+00:00 https://tr.psychopharmacologyinstitute.com/section/psikiyatride-klozapini-asiri-mi-degerlendiriyoruz-yoksa-yeterince-mi-kullanmiyoruz-tedaviye-direncli-sizofrenide-klozapin-ile-ikinci-kusak-antipsikotiklerin-karsilastirmasi-tr/ 2026-09-01T14:57:17+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreni-algoritmasi-ilk-epizot-icin-antipsikotik-secimi-tr/ 2026-09-01T14:57:26+00:00 https://tr.psychopharmacologyinstitute.com/section/ssri-yan-etkileri-zamanla-duzeliyor-mu-tr/ 2026-09-01T14:57:30+00:00 https://tr.psychopharmacologyinstitute.com/section/torsades-de-pointes-antidepresanlarin-ve-antipsikotiklerin-etkisi-tr/ 2026-09-01T14:57:34+00:00 https://tr.psychopharmacologyinstitute.com/section/psikedelikler-madde-kullanim-bozukluklarinin-tedavisinde-etkili-midir-tr/ 2026-09-01T14:57:38+00:00 https://tr.psychopharmacologyinstitute.com/section/cayin-ruh-sagligi-uzerindeki-etkilerinin-arkasindaki-norobilim-tr/ 2026-09-01T14:57:42+00:00 https://tr.psychopharmacologyinstitute.com/section/mikst-ozellikli-depresyonda-lumateperone-etkili-mi-tr/ 2026-09-01T14:57:51+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklere-bagli-kilo-alimi-glp-1-agonistleri-etkili-mi-tr/ 2026-09-01T14:57:55+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-depresyon-augmentasyon-icin-lityum-mu-quetiapine-mi-tr/ 2026-09-01T14:57:59+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlar-demans-hastalarinda-bilisi-kotulestirir-mi-tr/ 2026-09-01T14:58:03+00:00 https://tr.psychopharmacologyinstitute.com/section/depresyon-ve-anksiyete-icin-probiyotikler-ve-prebiyotikler-bagirsak-zihni-iyilestirebilir-mi-tr/ 2026-09-01T14:58:07+00:00 https://tr.psychopharmacologyinstitute.com/section/integrate-yeni-sizofreni-tedavi-kilavuzlari-tr/ 2026-09-01T14:58:15+00:00 https://tr.psychopharmacologyinstitute.com/section/lurasidon-komorbid-anksiyete-ile-birlikte-gorulen-bipolar-depresyonda-etkili-midir-tr/ 2026-09-01T14:58:18+00:00 https://tr.psychopharmacologyinstitute.com/section/ssri-lar-oral-antikoagulanlarla-birlikte-kullanildiginda-major-kanama-riskini-artiriyor-mu-tr/ 2026-09-01T14:58:22+00:00 https://tr.psychopharmacologyinstitute.com/section/kardiyovaskuler-hastaligi-olan-hastalarda-sertralin-psikiyatristlerin-bilmesi-gerekenler-tr/ 2026-09-01T14:58:27+00:00 https://tr.psychopharmacologyinstitute.com/section/yuksek-tuz-tuketimi-depresyon-ve-anksiyete-riskini-artiriyor-mu-tr/ 2026-09-01T14:58:30+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-bipolar-depresyon-yardimci-pramipeksol-bir-secenek-mi-tr/ 2026-09-01T14:58:38+00:00 https://tr.psychopharmacologyinstitute.com/section/semaglutid-sizofrenide-klozapin-kaynakli-kilo-alimini-geri-dondurur-mu-coast-calismasindan-sonuclar-tr/ 2026-09-01T14:58:42+00:00 https://tr.psychopharmacologyinstitute.com/section/kannabise-bagli-psikoz-hangi-antipsikotikler-hastaneye-yatisi-en-iyi-onler-tr/ 2026-09-01T14:58:46+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-depresyon-hangi-tedaviler-en-etkili-bir-ag-meta-analizi-tr/ 2026-09-01T14:58:50+00:00 https://tr.psychopharmacologyinstitute.com/section/depresyon-ve-anksiyetede-bagirsak-mikrobiyotasi-degisiyor-mu-tr/ 2026-09-01T14:58:54+00:00 https://tr.psychopharmacologyinstitute.com/section/klozapin-anc-izlemi-icin-yeni-kilavuzlar-tr/ 2026-09-01T14:59:01+00:00 https://tr.psychopharmacologyinstitute.com/section/yasli-eriskinlerde-bipolar-bozukluk-icin-cariprazine-dozlamasi-tr/ 2026-09-01T14:59:05+00:00 https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugunda-semaglutid-yeni-rkc-verileri-tr/ 2026-09-01T14:59:09+00:00 https://tr.psychopharmacologyinstitute.com/section/geriatrik-depresyon-optimizasyon-stratejileri-ve-sik-karsilasilan-guclukler-tr/ 2026-09-01T14:59:13+00:00 https://tr.psychopharmacologyinstitute.com/section/safran-depresyon-ve-anksiyete-tedavisinde-ssri-lar-kadar-etkili-mi-yeni-meta-analiz-tr/ 2026-09-01T14:59:17+00:00 https://tr.psychopharmacologyinstitute.com/section/karxt-xanomeline-trospium-sizofreni-tedavisinde-ne-kadar-etkili-nnt-ve-nnh-aciklamasi-tr/ 2026-09-01T14:59:24+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonda-parlak-isik-tedavisi-isbd-klinik-onerileri-tr/ 2026-09-01T14:59:28+00:00 https://tr.psychopharmacologyinstitute.com/section/iv-haloperidol-kardiyak-guvenlik-endiseleri-abartiliyor-mu-tr/ 2026-09-01T14:59:32+00:00 https://tr.psychopharmacologyinstitute.com/section/vareniklin-ve-bupropion-alkol-kullanim-bozuklugunun-tedavisinde-etkili-mi-tr/ 2026-09-01T14:59:36+00:00 https://tr.psychopharmacologyinstitute.com/section/ashwagandha-hafif-kognitif-bozuklukta-etkili-mi-tr/ 2026-09-01T14:59:41+00:00 https://tr.psychopharmacologyinstitute.com/section/ondansetron-sizofrenide-negatif-semptomlar-icin-etkili-midir-tr/ 2026-09-01T14:59:48+00:00 https://tr.psychopharmacologyinstitute.com/section/lityum-orotat-alzheimer-hastaligi-icin-cigir-acan-bir-tedavi-mi-tr/ 2026-09-01T14:59:52+00:00 https://tr.psychopharmacologyinstitute.com/section/duygudurum-dengeleyicilere-kimin-yanit-verecegini-ongorebilir-miyiz-tr/ 2026-09-01T14:59:56+00:00 https://tr.psychopharmacologyinstitute.com/section/ssri-augmentasyonu-doz-optimizasyonundan-ustun-mudur-tr/ 2026-09-01T15:00:00+00:00 https://tr.psychopharmacologyinstitute.com/section/alkol-kullanim-bozuklugu-olan-hastalarda-insomni-tedavisinde-trazodon-guvenli-midir-tr/ 2026-09-01T15:00:05+00:00 https://tr.psychopharmacologyinstitute.com/section/oral-antipsikotik-degisimi-alti-strateji-ve-ipucu-tr/ 2026-09-01T15:00:14+00:00 https://tr.psychopharmacologyinstitute.com/section/deliryum-sonrasi-antipsikotiklerin-birakilmasi-neden-onemlidir-tr/ 2026-09-01T15:00:18+00:00 https://tr.psychopharmacologyinstitute.com/section/ksilasin-tranq-dope-asiri-dozu-klinisyenlerin-bilmesi-gerekenler-tr/ 2026-09-01T15:00:22+00:00 https://tr.psychopharmacologyinstitute.com/section/pramipeksol-tedaviye-direncli-depresyonda-etkili-midir-tr/ 2026-09-01T15:00:26+00:00 https://tr.psychopharmacologyinstitute.com/section/jenerik-ilaclar-gercekten-orijinalleriyle-birbirinin-yerine-kullanilabilir-mi-tr/ 2026-09-01T15:00:30+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-sizofreni-klozapin-yerine-yuksek-doz-olanzapin-dusunmeli-misiniz-tr/ 2026-09-01T15:00:38+00:00 https://tr.psychopharmacologyinstitute.com/section/geriatrik-depresyonda-antidepresan-guclendirmesi-ve-ilac-degisimi-optimum-calismasindan-temel-bulgular-tr/ 2026-09-01T15:00:41+00:00 https://tr.psychopharmacologyinstitute.com/section/glp-1-agonistleri-lityum-duzeylerini-yukseltebilir-mi-tr/ 2026-09-01T15:00:45+00:00 https://tr.psychopharmacologyinstitute.com/section/inflamatuvar-belirtecler-antidepresan-tedavi-secimini-yonlendirebilir-mi-tr/ 2026-09-01T15:00:49+00:00 https://tr.psychopharmacologyinstitute.com/section/panik-bozuklugu-propranolol-erken-somatik-semptomlar-icin-faydali-olabilir-mi-tr/ 2026-09-01T15:00:54+00:00 https://tr.psychopharmacologyinstitute.com/section/uzun-donemde-zanomelin-trospiyum-etkinlik-ve-guvenlilik-bir-yil-sonra-da-gecerli-mi-tr/ 2026-09-01T15:01:02+00:00 https://tr.psychopharmacologyinstitute.com/section/trazodon-ile-insomni-ve-eslik-eden-depresyon-aasm-kilavuzlari-ne-kadar-gecerli-tr/ 2026-09-01T15:01:06+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-bozuklukta-antidepresanlar-sanilandan-daha-guvenli-mi-yeni-veriler-koklu-inanclara-meydan-okudugunda-tr/ 2026-09-01T15:01:10+00:00 https://tr.psychopharmacologyinstitute.com/section/gec-baslangicli-depresyon-enflamasyona-odaklanma-tr/ 2026-09-01T15:01:14+00:00 https://tr.psychopharmacologyinstitute.com/section/adhd-hastalarinda-stimulan-kotuye-kullanimi-ve-saptirma-ne-kadar-yaygindir-tr/ 2026-09-01T15:01:19+00:00 https://tr.psychopharmacologyinstitute.com/section/z-ilaclari-gebeligin-ilk-trimesterinde-guvenli-midir-tr/ 2026-09-01T15:01:28+00:00 https://tr.psychopharmacologyinstitute.com/section/lityuma-bagli-bobrek-fonksiyon-kaybi-sglt2-inhibitorleri-yardimci-olabilir-mi-tr/ 2026-09-01T15:01:33+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreni-yedi-antipsikotik-arasinda-akut-etkinlik-ve-guvenlilik-acisindan-hangi-kazaniyor-tr/ 2026-09-01T15:01:37+00:00 https://tr.psychopharmacologyinstitute.com/section/hafif-depresyon-takviyeler-ve-bitkisel-urunler-makul-birinci-basamak-secenekler-midir-tr/ 2026-09-01T15:01:41+00:00 https://tr.psychopharmacologyinstitute.com/section/madde-kullanimina-bagli-psikoz-uzun-vadede-antipsikotik-tedaviyi-kimler-surduruyor-tr/ 2026-09-01T15:01:45+00:00 https://tr.psychopharmacologyinstitute.com/section/kadinlarda-ilk-epizod-psikoz-hangi-antipsikotik-tercih-edilmeli-tr/ 2026-09-01T15:01:52+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-sizofreni-klozapin-bir-secenek-olmadiginda-ne-ise-yarar-tr/ 2026-09-01T15:01:56+00:00 https://tr.psychopharmacologyinstitute.com/section/insomnia-ilaclari-gercek-dunya-verilerinde-kotuye-kullanim-potansiyeli-nedir-tr/ 2026-09-01T15:02:00+00:00 https://tr.psychopharmacologyinstitute.com/section/ketamin-depresyon-tedavisinde-midazolam-dan-ustun-mu-tr/ 2026-09-01T15:02:04+00:00 https://tr.psychopharmacologyinstitute.com/section/antosiyaninler-ve-bilissel-islev-kanitlar-ne-gosteriyor-tr/ 2026-09-01T15:02:08+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoni-antipsikotiklerden-her-zaman-kacinilmali-mi-tr/ 2026-09-01T15:02:15+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-depresyonunda-antidepresanlar-tartismaya-bir-bakis-tr/ 2026-09-01T15:02:20+00:00 https://tr.psychopharmacologyinstitute.com/section/yalnizca-bir-basarisiz-antipsikotikten-sonra-klozapin-baslanmali-mi-tr/ 2026-09-01T15:02:24+00:00 https://tr.psychopharmacologyinstitute.com/section/alkolsuz-icecek-tuketimi-major-depresif-bozuklukla-baglantili-mi-tr/ 2026-09-01T15:02:29+00:00 https://tr.psychopharmacologyinstitute.com/section/atipik-depresyon-ayri-bir-klinik-alt-tip-mi-tr/ 2026-09-01T15:02:33+00:00 https://tr.psychopharmacologyinstitute.com/section/katatoni-antipsikotikler-nuksu-onleyebilir-mi-tr/ 2026-09-01T15:02:42+00:00 https://tr.psychopharmacologyinstitute.com/section/major-depresyon-icin-en-iyi-ek-antipsikotik-hangisi-tr/ 2026-09-01T15:02:46+00:00 https://tr.psychopharmacologyinstitute.com/section/akut-sizofreni-hangi-antipsikotikler-en-etkili-ve-tolere-edilebilir-tr/ 2026-09-01T15:02:50+00:00 https://tr.psychopharmacologyinstitute.com/section/glp-1-reseptor-agonistlerinin-anksiyete-uzerine-etkisi-nedir-tr/ 2026-09-01T15:02:54+00:00 https://tr.psychopharmacologyinstitute.com/section/hastalarin-vaping-i-birakmasina-hangi-tedaviler-gercekten-yardimci-oluyor-tr/ 2026-09-01T15:02:57+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreni-tedavisinde-uzun-etkili-enjektabl-antipsikotiklerin-rolu-tr/ 2026-09-01T15:03:28+00:00 https://tr.psychopharmacologyinstitute.com/section/lai-receteleme-zamanlamasinin-anlasilmasi-tr/ 2026-09-01T15:03:31+00:00 https://tr.psychopharmacologyinstitute.com/section/neden-lai-tercih-edilmeli-sizofrenide-uzun-etkili-enjektabl-ilaclarin-faydalari-tr/ 2026-09-01T15:03:35+00:00 https://tr.psychopharmacologyinstitute.com/section/riskleri-dengelemek-uee-tedavisinin-zorluklari-tr/ 2026-09-01T15:03:38+00:00 https://tr.psychopharmacologyinstitute.com/section/konusmayi-yonlendirmek-hastalarla-lai-lar-hakkinda-nasil-konusulur-tr/ 2026-09-01T15:03:42+00:00 https://tr.psychopharmacologyinstitute.com/section/uygulamada-lai-lar-haloperidol-ve-fluphenazine-tr/ 2026-09-01T15:03:47+00:00 https://tr.psychopharmacologyinstitute.com/section/pratikte-uei-ler-aripiprazol-olanzapin-tr/ 2026-09-01T15:03:51+00:00 https://tr.psychopharmacologyinstitute.com/section/pratikte-uai-ler-paliperidon-risperidon-tr/ 2026-09-01T15:03:55+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vaka-tr/ 2026-09-01T15:03:59+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-9010-tr/ 2026-09-01T15:04:02+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-okb-nin-anlasilmasi-ve-tanilanmasi-tr/ 2026-09-01T15:04:10+00:00 https://tr.psychopharmacologyinstitute.com/section/okb-tedavi-stratejilerine-genel-bakis-tr/ 2026-09-01T15:04:14+00:00 https://tr.psychopharmacologyinstitute.com/section/okb-de-ssri-dozlamasi-fda-kilavuzlarinin-otesinde-tr/ 2026-09-01T15:04:17+00:00 https://tr.psychopharmacologyinstitute.com/section/birinci-basamak-tedavilerin-otesinde-okb-yonetimi-tr/ 2026-09-01T15:04:21+00:00 https://tr.psychopharmacologyinstitute.com/section/okb-augmentasyon-stratejilerine-genel-bakis-tr/ 2026-09-01T15:04:25+00:00 https://tr.psychopharmacologyinstitute.com/section/okb-de-glutamaterjik-guclendirme-memantine-riluzole-lamotrigin-ve-diger-ajanlar-tr/ 2026-09-01T15:04:30+00:00 https://tr.psychopharmacologyinstitute.com/section/okb-augmentasyonunda-ikinci-kusak-antipsikotikler-ucuncu-basamak-ajanlar-tr/ 2026-09-01T15:04:33+00:00 https://tr.psychopharmacologyinstitute.com/section/diger-okb-guclendirme-ajanlari-buspiron-ondansetron-ve-gelismekte-olan-secenekler-tr/ 2026-09-01T15:04:37+00:00 https://tr.psychopharmacologyinstitute.com/section/okb-icin-norostimulasyon-tms-ve-dbs-tr/ 2026-09-01T15:04:41+00:00 https://tr.psychopharmacologyinstitute.com/section/okb-icin-ablatif-cerrahi-tr/ 2026-09-01T15:04:46+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vaka-augmentasyondan-once-ssri-in-optimize-edilmesi-tr/ 2026-09-01T15:04:50+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-tr/ 2026-09-01T15:04:54+00:00 https://tr.psychopharmacologyinstitute.com/section/dehb-ilaclari-ve-kardiyak-yan-etkiler-kanitlar-gercekte-ne-gosteriyor-tr/ 2026-09-01T15:05:02+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlar-ve-antikoagulanlar-kanama-riskinin-yonetimi-tr/ 2026-09-01T15:05:06+00:00 https://tr.psychopharmacologyinstitute.com/section/antikoagulan-kullanan-hastalarda-antipsikotik-secimi-ilac-etkilesimleri-ve-daha-guvenli-alternatifler-tr/ 2026-09-01T15:05:10+00:00 https://tr.psychopharmacologyinstitute.com/section/duygu-durum-dengeleyiciler-ve-antikoagulasyon-valproat-karbamazepin-lityum-ve-lamotrijin-tr/ 2026-09-01T15:05:15+00:00 https://tr.psychopharmacologyinstitute.com/section/hemodiyalizde-antidepresanlar-kardiyak-guvenlilik-ve-doz-ayarlamalari-tr/ 2026-09-01T15:05:20+00:00 https://tr.psychopharmacologyinstitute.com/section/hemodiyalizde-antipsikotikler-depo-stratejileri-qt-riski-ve-ilaca-ozgu-dozlama-tr/ 2026-09-01T15:05:25+00:00 https://tr.psychopharmacologyinstitute.com/section/hemodiyalizde-duygudurum-dengeleyiciler-lityum-valproat-ve-lamotrijin-dozaji-tr/ 2026-09-01T15:05:29+00:00 https://tr.psychopharmacologyinstitute.com/section/hasta-yutamadiginda-antidepresanlar-uygulama-yollari-mevcut-ilaclar-ve-pratik-rehberlik-tr/ 2026-09-01T15:05:33+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vaka-sizoaffektif-bozukluk-miyokard-enfarktusu-ve-akut-bobrek-hasari-tr/ 2026-09-01T15:05:38+00:00 https://tr.psychopharmacologyinstitute.com/section/eve-goturulecek-mesajlar-tr/ 2026-09-01T15:05:42+00:00 https://tr.psychopharmacologyinstitute.com/section/fiziksel-hastalik-ve-madde-kullanim-bozukluklari-cift-yonlu-bir-iliski-tr/ 2026-09-01T15:05:50+00:00 https://tr.psychopharmacologyinstitute.com/section/madde-kullanim-bozukluklarinda-hepatik-komplikasyonlar-risk-faktorleri-ve-hastalik-progresyonu-tr/ 2026-09-01T15:05:55+00:00 https://tr.psychopharmacologyinstitute.com/section/karaciger-hastaligi-ve-maud-disulfiram-naltrexone-ve-acamprosate-in-onceliklendirilmesi-tr/ 2026-09-01T15:05:59+00:00 https://tr.psychopharmacologyinstitute.com/section/karaciger-hastaligi-buprenorfin-metadon-ve-sigarayi-birakma-ajanlari-tr/ 2026-09-01T15:06:03+00:00 https://tr.psychopharmacologyinstitute.com/section/hiv-hepatitis-c-ve-bagimlilik-buprenorfin-metadon-naltreks-ve-disulfiramin-antivirallerle-birlikte-ayarlanmasi-tr/ 2026-09-01T15:06:07+00:00 https://tr.psychopharmacologyinstitute.com/section/renal-yetmezlik-ve-bagimlilik-farmakoterapisi-naltrexone-acamprosate-gabapentin-ve-topiramate-doz-ayarlamalari-tr/ 2026-09-01T15:06:11+00:00 https://tr.psychopharmacologyinstitute.com/section/koah-uyku-apnesi-ve-bagimlilik-farmakoterapisi-metadon-buprenorfin-gabapentin-ve-baklofen-tr/ 2026-09-01T15:06:15+00:00 https://tr.psychopharmacologyinstitute.com/section/kardiyovaskuler-hastalik-ve-bagimlilik-farmakoterapisi-qtc-riski-sigara-birakma-ve-disulfiram-guvenligi-tr/ 2026-09-01T15:06:19+00:00 https://tr.psychopharmacologyinstitute.com/section/vaka-yukselmis-transaminazlarla-birlikte-alkol-kullanim-bozuklugu-tr/ 2026-09-01T15:06:23+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-10210-tr/ 2026-09-01T15:06:27+00:00 https://tr.psychopharmacologyinstitute.com/section/tssb-psikofarmakoloji-algoritmasi-giris-ve-genel-bakis-tr/ 2026-09-01T15:06:34+00:00 https://tr.psychopharmacologyinstitute.com/section/ptsd-ozel-durumlar-madde-kullanimi-bipolar-bozukluk-psikoz-ve-gebelik-tr/ 2026-09-01T15:06:39+00:00 https://tr.psychopharmacologyinstitute.com/section/ptsd-de-uyku-bozukluklarinin-degerlendirilmesi-kabus-uyanma-ve-uyku-teroru-tr/ 2026-09-01T15:06:43+00:00 https://tr.psychopharmacologyinstitute.com/section/ptsd-kabuslarda-prazosin-erkekler-ve-kadinlar-icin-dozlama-protokolleri-tr/ 2026-09-01T15:06:47+00:00 https://tr.psychopharmacologyinstitute.com/section/ptsd-de-uyku-baslatma-hidroksizin-trazodon-ve-klonidin-tr/ 2026-09-01T15:06:51+00:00 https://tr.psychopharmacologyinstitute.com/section/ketiapin-benzodiazepinler-ve-trisiklikler-tssb-ye-bagli-uyku-sorunlarinda-neden-kacinilmali-tr/ 2026-09-01T15:06:55+00:00 https://tr.psychopharmacologyinstitute.com/section/ptsd-icin-ssri-secimi-sertralin-paroksetin-ve-essitalopram-tr/ 2026-09-01T15:07:00+00:00 https://tr.psychopharmacologyinstitute.com/section/ptsd-ile-psikotik-belirtilerde-antipsikotikler-risperidon-aripiprazol-ve-ketiapin-tr/ 2026-09-01T15:07:03+00:00 https://tr.psychopharmacologyinstitute.com/section/ikinci-basamak-ptsd-tedavisi-venlafaksin-duloksetin-ve-mirtazapin-tr/ 2026-09-01T15:07:07+00:00 https://tr.psychopharmacologyinstitute.com/section/tssb-tedavisinde-ucuncu-basamak-hiperarousal-icin-gunduz-prazosin-ve-klonidin-tr/ 2026-09-01T15:07:11+00:00 https://tr.psychopharmacologyinstitute.com/section/tedaviye-direncli-ptsd-topiramat-antipsikotikler-ve-guclendirme-secenekleri-tr/ 2026-09-01T15:07:16+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-10912-tr/ 2026-09-01T15:07:20+00:00 https://tr.psychopharmacologyinstitute.com/section/yeme-bozukluklarinin-yonetimi-genel-bakis-ve-klinik-vaka-tr/ 2026-09-01T15:07:28+00:00 https://tr.psychopharmacologyinstitute.com/section/bulimia-nervoza-etkili-ilac-tedavileri-tr/ 2026-09-01T15:07:33+00:00 https://tr.psychopharmacologyinstitute.com/section/bulimia-nervoza-tedavisinde-ilac-recete-ederken-dikkat-edilmesi-gereken-temel-hususlar-tr/ 2026-09-01T15:07:37+00:00 https://tr.psychopharmacologyinstitute.com/section/anoreksiya-nervozada-farmakoterapinin-rolu-tr/ 2026-09-01T15:07:41+00:00 https://tr.psychopharmacologyinstitute.com/section/anoreksiya-ile-birlikte-gorulen-duygudurum-belirtileri-hedefe-yonelik-farmakolojik-yaklasim-tr/ 2026-09-01T15:07:45+00:00 https://tr.psychopharmacologyinstitute.com/section/tikinircasina-yeme-bozuklugunda-farmakoterapi-antidepresanlar-ve-antikonvulzanlar-tr/ 2026-09-01T15:07:50+00:00 https://tr.psychopharmacologyinstitute.com/section/tikinircasina-yeme-bozuklugu-farmakoterapisi-lisdeksamfetamin-tr/ 2026-09-01T15:07:54+00:00 https://tr.psychopharmacologyinstitute.com/section/klinik-vaka-bulimia-nervoza-da-tedavi-kararlari-tr/ 2026-09-01T15:07:58+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-8109-tr/ 2026-09-01T15:08:02+00:00 https://tr.psychopharmacologyinstitute.com/section/ilk-epizod-sizofrenide-bilissel-islev-ve-tedavi-yanit-yorungeleri-prospektif-kohort-calismasindan-kanitlar-tr/ 2026-09-09T00:54:47+00:00 https://tr.psychopharmacologyinstitute.com/section/major-depresif-bozuklugu-olan-yetiskinlerin-idame-fazinda-antidepresanlarla-tedavisi-sistematik-bir-derleme-ve-ag-meta-analizi-tr/ 2026-09-09T00:54:51+00:00 https://tr.psychopharmacologyinstitute.com/section/klozapin-direncinde-augmentasyon-stratejileri-sistematik-bir-derleme-ve-meta-analiz-tr/ 2026-09-09T00:54:55+00:00 https://tr.psychopharmacologyinstitute.com/section/c-reaktif-protein-klinik-pratikte-ssri-larin-etkinligini-ongorebilir-gercek-dunyada-genis-orneklemli-bir-kohort-calismasi-tr/ 2026-09-09T00:54:58+00:00 https://tr.psychopharmacologyinstitute.com/section/anksiyolitik-ilac-silexan-in-uyku-uzerine-etkisi-narratif-bir-derleme-tr/ 2026-09-09T00:55:02+00:00 https://tr.psychopharmacologyinstitute.com/section/gebelikte-antidepresanlar-otizm-ve-dehb-riskini-artirir-mi-tr/ 2026-09-09T02:10:39+00:00 https://tr.psychopharmacologyinstitute.com/section/ssri-lar-antipsikotiklere-eklendiginde-aritmi-ve-ani-olum-riskini-artirir-mi-tr/ 2026-09-09T02:10:44+00:00 https://tr.psychopharmacologyinstitute.com/section/notropeni-sonrasi-klozapin-yeniden-baslatma-mutlak-mi-yoksa-goreli-mi-kontrendikasyon-tr/ 2026-09-09T02:10:48+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreniye-yeniden-isim-mi-verilmeli-tr/ 2026-09-09T02:10:52+00:00 https://tr.psychopharmacologyinstitute.com/section/uyku-icin-ashwagandha-ve-melatonin-ikisi-birlikte-daha-mi-etkili-tr/ 2026-09-09T02:10:57+00:00 https://tr.psychopharmacologyinstitute.com/section/psikotropiklerin-kardiyovaskuler-etkileri-kan-basinci-kalp-hizi-ve-kanama-riski-tr/ 2026-09-10T18:26:52+00:00 https://tr.psychopharmacologyinstitute.com/section/stimulanlarin-ve-stimulan-olmayan-dehb-ilaclarinin-kardiyovaskuler-etkileri-tr/ 2026-09-10T18:26:57+00:00 https://tr.psychopharmacologyinstitute.com/section/antipsikotiklerle-qt-uzamasi-risk-siniflandirmasi-ve-ekg-izlemi-tr/ 2026-09-10T18:27:01+00:00 https://tr.psychopharmacologyinstitute.com/section/iv-haloperidol-ve-torsades-de-pointes-mitosu-kanittan-ayirt-etmek-tr/ 2026-09-10T18:27:06+00:00 https://tr.psychopharmacologyinstitute.com/section/klozapin-kaynakli-miyokardit-ve-kardiyomiyopati-tanima-ve-izleme-tr/ 2026-09-10T18:27:11+00:00 https://tr.psychopharmacologyinstitute.com/section/antidepresanlarla-qt-uzamasi-bir-risk-siralamasi-tr/ 2026-09-10T18:27:15+00:00 https://tr.psychopharmacologyinstitute.com/section/lityum-lamotrijin-ve-diger-duygudurum-duzenleyicilerin-kardiyak-etkileri-tr/ 2026-09-10T18:27:19+00:00 https://tr.psychopharmacologyinstitute.com/section/metadon-donepezil-ve-ibogain-ile-qt-uzamasi-tr/ 2026-09-10T18:27:24+00:00 https://tr.psychopharmacologyinstitute.com/section/qtc-ve-psikiyatrik-ilaclar-hakkinda-yedi-yanlis-kani-tr/ 2026-09-10T18:27:29+00:00 https://tr.psychopharmacologyinstitute.com/section/vaka-yuksek-kardiyak-riskli-bir-hastada-ajitasyon-ve-uzamis-qtc-tr/ 2026-09-10T18:27:33+00:00 https://tr.psychopharmacologyinstitute.com/section/temel-mesajlar-11511-tr/ 2026-09-10T18:27:38+00:00 https://tr.psychopharmacologyinstitute.com/section/kadinlarda-psikoz-hormonal-durum-receteleme-kararlarinizi-etkilemeli-mi-tr/ 2026-09-10T18:27:47+00:00 https://tr.psychopharmacologyinstitute.com/section/sizofreni-antipsikotik-kaynakli-kilo-aliminda-semaglutid-liraglutidden-ustun-mu-tr/ 2026-09-10T18:27:52+00:00 https://tr.psychopharmacologyinstitute.com/section/bipolar-surdurum-tedavisi-ilaclari-gercek-dunya-etkinligine-gore-siralama-tr/ 2026-09-10T18:27:56+00:00 https://tr.psychopharmacologyinstitute.com/section/dusuk-dozlu-lityum-karbonat-hafif-bilissel-bozuklukta-bilissel-gerilemeyi-yavaslatiyor-mu-tr/ 2026-09-10T18:28:01+00:00 https://tr.psychopharmacologyinstitute.com/section/ciddi-ruhsal-hastaliklarda-ketojenik-terapi-uzman-konsensusu-tr/ 2026-09-10T18:28:06+00:00